Stay updated on Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:40:47.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the lapse-in-funding notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T10:55:20.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A system-wide notice about a lapse in government funding and NIH operating status was added at the top, and the revision tag was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T06:18:02.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Glossary visibility was added and revision metadata updated to v3.4.0, with the new display of 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' labels; the old 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' labels and revision v3.3.4 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:19:33.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4, replacing Revision: v3.3.3. This is a minor metadata update with no impact on study content or user actions.
    Difference
    0.1%
    Check dated 2026-01-14T02:47:12.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The page now lists a Locations section with Michigan as a location, and the HHS Vulnerability Disclosure and Michigan Locations entries have been removed. The page revision is updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T17:30:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page.